GTRV becomes the French Society of Nanomedicine

Newsletter n°3 - June 2013
GTRV becomes the French Society of Nanomedicine
CONTENTS
G
Audience
TRV association was founded
twenty years ago as the
“Groupe Thématique de Recherche sur les
Vecteurs” by three leading scientists from
public sector laboratories in France: Patrick
Couvreur, Francis Schuber and Jean Phillipot. It was registered as a non-profitmaking organization with the aim of encouraging scientific collaboration between
research groups interested in delivery systems or their targets.
The members of the GTRV have a wide
range of scientific backgrounds (chemistry,
physics, biology, pharmacy, medicine) and
are drawn from both the public sector
(universities and state research organisations such as CNRS and INSERM) and industry, particularly the pharmaceutical and
cosmetic industries. Since the GTRV has no
paid staff, the cost of the Annual Meeting
remains low, encouraging student participation.
2012 Event
Mission
Towards the Nanomedicine
Highlights of the annual
meeting
The activity of the GTRV turns around its
Annual Meeting, held during two days in
December and attended by 150-200 delegates. The venue alternates between Paris
and other French cities; in 1997 the meeting was held in Brussels. The programme
includes 4 to 6 invited lectures, in English
or French, together with podium and poster free communications. A dinner and,
often, a visit to a local place of interest
allow for more informal contacts. Since
1995, an award endowed by Sanofi Aventis
has been given for the best communication
from a young scientist. Debio RP now endows a second award, which has been presented for the first time at the Annual
Meeting in Montpellier in December 2005.
GTRV & Nanomedicine
GTRV Board
2013 Annual Meeting
Save the date now !
N
anotechnologies for Health have
always been the center of interest of the members of the GTRV. The research of our members is now at the frontier
between delivery and imaging. To maintain
the network of the French community at the
top level, we propose to evolve towards the
French Society of Nanomedicine.
This name is fully consistent with its scientific interests and the desire to see the
French groups involved in this field evolving
in a recognize environment.
The GTRV board is happy to launch the
French Society of Nanomedicine.
We invite you to join us, participate or propose new actions to be part of
the nanomedicine mutation!
VISIT our new website at www.gtrv.fr
GTRV Board & Expertise
President
Secretary
Dr. Nathalie MIGNET
CNRS researcher
UMR 8151/Inserm U1022
University Paris Descartes
Paris, France
Expertise:
Nanomedecine and molecular imaging,
Non viral gene therapy
Pr. Catherine PASSIRANI
Inserm U1066
University of Angers
Angers, France
Expertise:
Nanocarriers, stealthiness, targeting
Non viral gene therapy (DNA, siRNA)
Treasurer
Dr. Sylvie BEGU
Gerhardt Institute - UMR5253
UFR Pharmaceutical Sciences
Montpellier, France
Expertise:
Drug Delivery: hybrid biomaterials,
nanoparticles (liposomes, polymers
micelles), Non viral gene therapy
Communication Pr. Bernard LEBLEU
UMR CNRS 5235-DIMNP– Group Leader
University Montpellier II
Montpellier, France
Expertise :
Cell penetrating peptides (TAT), oligonucleotide delivery, protein-protein
interactions
Sponsoring
Pr. Didier BETBEDER
EA 2689 IFR 114 - Lab. of Physiology
University Lille Nord de France
Lille, France
Expertise:
Nanocarriers, targeting, delivery
through airway and BBB, protein transfection, vaccine
Communication Pr. Véronique PREAT
Louvain Drug Research Institute
Université catholique de Louvain
Bruxelles - Belgium
Expertise:
Drug delivery, polymeric nanoparticles,
targeting,
non viral gene therapy
Pr. P. COUVREUR
UMR CNRS 8612
Faculty of Pharmacy
Châtenay-Malabry,
France
Vice-President
Secretary
Vice-Treasurer
Communication
Dr. Sergio CAPANCIONI
Head of Drug Delivery
Debio R.P. SA
Prospection & Evaluation
Martigny, Switzerland
Expertise:
Drug Delivery Systems
Targeted therapies
Dr. Marie-Pierre ROLS
UMR-CNRS 5089 - DR1-CNRS - Group leader
Pharmacology & Structural Biology Institute
Toulouse, France
Expertise:
Cell biophysics, vectorisation, drug delivery,
electroporation, cell imaging, non viral gene
therapy
Dr. Benoit FRISCH
UMR CNRS 7199 - CNRS researcher
Faculty of Pharmacy
Illkirch, France
Expertise:
Vaccines, Immuno-adjuvant, Liposomes, Bioconjugate chemistry, Drug delivery, Biomaterials, Polymers
Dr. Anne-Claude COUFFIN
CEA LETI - Projet Leader
Campus Minatec
Grenoble, France
Expertise:
Nanocarriers, Targeting, Fluorescence Imaging
Sponsoring
Dr. Harivardhan REDDY LAKKIREDDY
Sanofi R&D
Vitry-sur-Seine, France
Expertise:
Drug delivery, Nanotechnology for disease
therapy
Webmaster
Dr. Jean Luc COLL
Inserm UJF U823
Albert Bonniot Institute
Grenoble, France
Expertise:
Targeted drug delivery, Oncology, Optical imaging, nanomedicine
Honorary members
Dr. G. BARRATT
UMR CNRS 8612
Faculty of Pharmacy
Châtenay-Malabry,
France
Dr. F. SCHUBER
UMR CNRS 7199
Faculty of Pharmacy
Illkirch,
France
Upcoming events
ORGANIZATION COMMITTEE
Patrick Midoux, Eva Toth, Chantal Pichon, Tristan Montier for local organization
Nathalie Mignet, Jean-Luc Coll, Benoit Frisch, Anne-Claude Couffin, Catherine Passirani for GTRV board
Join us and support GTRV in 2013 !
FOR REGISTRATION INFORMATION: www.gtrv.fr
Flash back on 2012 GTRV Annual meeting
The last annual meeting took place in Chilly Mazarin at Sanofi Research & Development in December 3-5, 2012
The GTRV/SANOFI PRIZE is dedicated to E.
Secret for her work on Multi-functionalized
porous silicon nanoparticles for cancer
therapy applications
The GTRV/DEBIOPHARM PRIZE is dedicated to J.
Lavaud for his work on “Development and multimodal imaging characterization of relevant models in oncology”
Editorial board
A.-C. Couffin
B. Lebleu
C. Passirani
M.-P. Rols
We offer you a Hall Exhibition along 3-day meeting to share your last technical
innovation with all attendees
For sponsoring opportunities please contact: [email protected]